Genetic counselling and gene mutation analysis in familial adenomatous polyposis in Western Australia.
OBJECTIVE
To assess the provision of accurate pre-symptomatic genetic testing with DNA analysis and appropriate counselling for individuals and families known to be at high risk of developing familial adenomatous polyposis coli (FAP).


METHODS
Thirty-one families with clinically and pathologically documented FAP were ascertained from the Western Australian Polyposis Registry. DNA was collected from over 200 individuals in these families to establish their genetic risk status for FAP, either by direct mutation analysis, or by linkage analysis. Individuals undergoing DNA testing were given intensive psychosocial support and counselling.


RESULTS
In 19 families DNA-based counselling could not be offered because either the adenomatous polyposis coli (APC) gene mutation could not be detected or there were insufficient family members for linkage analysis. Gene testing yielded mutations of the APC gene in 87 individuals from 12 families; by gene tracking (or linkage analysis) in three families and by mutation analysis in the remaining nine (four of which had only one affected individual). DNA results conformed with a definite clinicopathological diagnosis in 27 FAP patients and, of the remaining 60 high-risk subjects tested, 14 had inherited the mutated APC gene.


CONCLUSIONS
DNA analysis allowed accurate genetic counselling for 12 of 31 families affected by FAP, thus improving the medical and personal management in asymptomatic people who would otherwise be subjected to the uncertainty of long term surveillance and repeated colonic examinations. In future a superior biomolecular approach to gene mutation analysis, such as the protein truncation test, will facilitate management for most FAP individuals and families.
Walpole
I R
IR
Genetic Services of Western Australia, King Edward Memorial Hospital for Women, Perth.
Kool
D A
DA
Edkins
T
T
Creegan
R
R
Levitt
S
S
Francis
S T
ST
Goldblatt
J
J
D011125:Adenomatous Polyposis Coli / Q000175:diagnosis* / Q000235:genetics / Q000628:therapy; D000293:Adolescent; D000328:Adult; D015342:DNA Probes; D005260:Female; D017491:Genes, APC; D005817:Genetic Counseling; D008040:Genetic Linkage; D005819:Genetic Markers; D006801:Humans; D008297:Male; D017354:Point Mutation; D012307:Risk Factors
D015342:DNA Probes; D005819:Genetic Markers